register

News - MedTech & Diagnostics

Stryker partners with academics and digital health enabler to advance innovative patient solutions

Health Industry Hub | November 14, 2023 |

MedTech & Diagnostics News: In a landmark collaboration, the Digital Health Collaborative Research Centre (DHCRC), in partnership with medtech leader Stryker and the University of Technology Sydney (UTS) is set to embark on a project that has the potential to reshape the landscape of patient healthcare through the development of a cutting-edge digital platform.

Stryker established its first Research and Development (R&D) Lab in Brisbane last year, focusing on key areas such as digital health, robotics, clinical software applications, and advanced manufacturing research.

Rob Wood, Senior Director of Research & Development at Stryker, emphasised the transformative potential of the project, stating, “A local, fully digitised and connected planning and design treatment system has the potential to reduce production lead times and hospital and patient costs, improve patient outcomes, and demonstrate scalability potential across multiple medical applications.”

The collaboration will see academia and industry working hand in hand, with a special research and development relationship established with UTS Rapido. UTS Rapido, a dedicated engineering and technology consultancy embedded within UTS, will provide expertise in additive manufacturing.

Hervé Harvard, Executive Director of UTS Rapido, explained “UTS Rapido has a proven track record of developing end-to-end solutions through its unique capabilities in software development, UX, and mechatronics.”

Annette Schmiede, CEO of DHCRC, underscored the potential impact of the project on the digital health sector and the broader Australian economy. She stated, “It is anticipated that the outcomes of this project will lead to job creation with localized product development in Australia, as well as an increase in local skill development. Longer term, this project has the potential to place Australia in a strong position to deliver digital solutions to the broader Asia Pacific region.”

The collaborative endeavour represents a unique fusion of global expertise, world-leading universities, and the local health sector. Annette Schmiede emphasised, “This reflects the core mission of the DHCRC.”

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News - Pharmaceuticals

Inside the tensions shaping PBAC decision

Inside the tensions shaping PBAC decision

Health Industry Hub | September 17, 2026 |

The evolving relationship between sponsors, the Pharmaceutical Benefits Advisory Committee (PBAC) and the health technology assessment (HTA) system came under […]

More


News - MedTech & Diagnostics

GenesisCare and Omico join forces in precision oncology as Australia sets national genomics agenda

GenesisCare and Omico join forces in precision oncology as Australia sets national genomics agenda

Health Industry Hub | September 17, 2026 |

GenesisCare and Omico are teaming up to bring precision oncology to more patients facing incurable, advanced or poor prognosis cancers. […]

More


News - MedTech & Diagnostics

MTAA Board election kicks off, setting stage for the next chapter in policy and advocacy

MTAA Board election kicks off, setting stage for the next chapter in policy and advocacy

Health Industry Hub | September 17, 2026 |

The race for six seats on the Medical Technology Association of Australia (MTAA) Board is underway, with 10 candidates nominated […]

More


News - Pharmaceuticals

New breast cancer drug fills gap left by Zoladex market withdrawal

New breast cancer drug fills gap left by Zoladex market withdrawal

Health Industry Hub | September 17, 2026 |

From 1 October 2026, Diphereline (triptorelin 3.75mg) will become available on the Pharmaceutical Benefits Scheme (PBS) for the treatment of […]

More


This content is copyright protected. Please subscribe to gain access.